The SIO Resident and Medical Student Section is proud to introduce the inaugural RMSS Immersive Virtual Training Course, taking place this fall on Saturday, 2 November 2024 10:00 AM - 3:15 PM ET. This half-day virtual course will offer didactic lectures reviewing procedural indications, technical considerations, procedure follow-up, and career development topics. This 100-200 level course will be broken down into two tracks, geared toward medical students and residents, allowing participants to tune in for either or both track according to their interests.
After this course, attendees should have acquired new and valuable knowledge about the scope of care and breadth of services that Interventional Oncology can provide to cancer patients via an informational and case-based curriculum. See the full course schedule below.
Register Now
Track 1: Introductory Program (100 Level)
Saturday, 2 November 2024 | 10:00 AM - 11:25 AM ET
Schedule
| Time |
Session Description |
| 10:00 - 10:10 a.m. |
Welcome & Introduction, Erica Alexander, MD, Memorial Sloan Kettering Cancer Center
|
| 10:10 - 10:45 a.m. |
Liver Directed Therapy: HCC & Metastatic Disease, Susan Shamimi-Noori, MD, University of Pennsylvania
- Review of guidelines/staging/role of IR in managing primary HCC
- Review of guidelines/role of IR in managing metastatic colorectal cancer
- Basics of Liver Ablation
- Basics of Liver Embolization (Bland, Chemoembolization, and Y90)
|
| 10:50 - 11:25 a.m. |
Lung Ablation, Vlasos Sotirchos, MD, Memorial Sloan Kettering Cancer Center
- The role of IR’s in the management of lung cancer (Review of guidelines, data supporting use of thermal ablation, and other MDT options)
- How to approach lung ablation- patient selection, procedure, and follow-up
|
Track 2: Joint Program (100-200 Level)
Saturday, 2 November 2024 | 11:30 AM - 12:45 PM ET
Schedule
| Time |
Session Description |
| 11:30 - 11:50 a.m. |
Oncologic Care (Patient Centered II), Eric Keller, MD, Delaney Radiology
- Trainee ethics in Interventional Radiology
- Patient decision aids in Interventional Radiology and their role in informed consent
|
| 11:50 a.m. - 12:10 p.m. |
Pain and Palliation, Musculoskeletal, Anthony Tadros, MD, University of California San Diego
- Overview of IR's role in pain management - a case based discussion
- Buildint a pain practice: patient selection, optimizing outcomes, and potential pitfalls
|
| 12:15 - 12:45 p.m. |
Career Development: Interventional Oncology in Academics vs Private Practice, vs OBL, Mikhail Silk, MD, NYU Lanone Health, Amy Deipolyi, MD, PhD, Charleston Area Medical Center
- Choosing your first job
- How to weigh different practice models
- Tips for new graduates with contract negotiation
|
Track 3: Advanced Program (200 Level)
Saturday, 2 November 2024 | 1:00 PM - 3:15 PM ET
Schedule
| Time |
Session Description |
| 1:15 - 1:55 p.m. |
Liver Directed Therapy: HCC Landmark Studies & Dosimetry, Role for other embolics, ablation; Liver Metastases, Daniel N. Depietro, MD, University of Pennsylvania
- Review of the literature and established role of IR procedures in the management of HCC
- Y90 How To: review of patient selection, Y90 dosing, and follow-up
- Ablation How To: patient and tumor selection and potential pitfalls
|
| 2:00 - 2:40 p.m. |
Master class lung interventions (considerations of ablation technology and bronchial artery embolization), Stephen Solomon, MD, Memorial Sloan Kettering Cancer Center
- MWA vs Cryo vs RFA vs newer ablation modalities – what to choose and when
- Advanced maneuvers: ablating lesions in tough locations
- Bronchial artery embolization: hemoptysis and lung TACE
|
| 2:45 - 3:15 p.m. |
Advanced course of renal malignancies (ablation considerations, use of renal stenting, pyeloperfusion), Ron Arellano, MD, FSIR, FACR, FCIRSE, Massachusetts General Hospital
- Guidelines and data for RCC ablation
- Patient and tumor selection
- Case based review: tough tumors and strategies for success
|
This offering is supported by:
